● Recruiting

Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial

Condition: Cardiovascular Disease · Sponsor: Amgen

PhasePhase 3

Planned participants406

Who can joinAll sexes, 35 Years to 80 Years

Healthy volunteersNo

About this study

The primary objective of this trial is to evaluate the effect of olpasiran, compared to placebo, on non-calcified plaque (NCP) volume as measured by Coronary Computed Tomography Angiography (CCTA).

This description comes directly from the study's public registry record.

Talk to the study team

Amgen Call Center · 866-572-6436 · medinfo@amgen.com

Always discuss trial participation with your own doctor first.

Locations (40)

Bridgeport Hospital	Bridgeport, Connecticut, United States	Recruiting
Jacksonville Center for Clinical Research	Jacksonville, Florida, United States	Recruiting
Midwest Heart and Vascular Specialists	Overland Park, Kansas, United States	Recruiting
Flourish Bowie	Bowie, Maryland, United States	Recruiting
Montefiore Medical Center - Bronx	Philadelphia, Pennsylvania, United States	Recruiting
Vital Heart and Vein	Humble, Texas, United States	Recruiting
Advara HeartCare Wesley	Auchenflower, Queensland, Australia	Recruiting
University of The Sunshine Coast Clinical Trials, Sippy Downs	Sippy Downs, Queensland, Australia	Recruiting
Advara HeartCare Leabrook	Leabrook, South Australia, Australia	Recruiting
North York Diagnostic and Cardiac Centre	Vaughan, Ontario, Canada	Recruiting
Peking University First Hospital	Beijing, Beijing Municipality, China	Recruiting
The First Affiliated Hospital of Zhengzhou University	Zhengzhou, Henan, China	Recruiting

+ 28 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07293260